445 related articles for article (PubMed ID: 16752559)
1. IMRT: improvement in treatment planning efficiency using NTCP calculation independent of the dose-volume-histogram.
Grigorov GN; Chow JC; Grigorov L; Jiang R; Barnett RB
Med Phys; 2006 May; 33(5):1250-8. PubMed ID: 16752559
[TBL] [Abstract][Full Text] [Related]
2. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
[TBL] [Abstract][Full Text] [Related]
3. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
4. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
Gordon JJ; Sayah N; Weiss E; Siebers JV
Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
[TBL] [Abstract][Full Text] [Related]
5. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
[TBL] [Abstract][Full Text] [Related]
8. Complementary Relation Between the Improvement of Dose Delivery Technique and PTV Margin Reduction in Dose-Escalated Radiation Therapy for Prostate Cancer.
Utsunomiya S; Yamamoto J; Tanabe S; Oishi M; Satsuma A; Kaidu M; Abe E; Ohta A; Kushima N; Aoyama H
Pract Radiat Oncol; 2019 May; 9(3):172-178. PubMed ID: 30772440
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.
Wang L; Movsas B; Jacob R; Fourkal E; Chen L; Price R; Feigenberg S; Konski A; Pollack A; Ma C
J Appl Clin Med Phys; 2004; 5(2):29-41. PubMed ID: 15738911
[TBL] [Abstract][Full Text] [Related]
10. A new method of incorporating systematic uncertainties in intensity-modulated radiotherapy optimization.
Yang J; Mageras GS; Spirou SV; Jackson A; Yorke E; Ling CC; Chui CS
Med Phys; 2005 Aug; 32(8):2567-79. PubMed ID: 16193787
[TBL] [Abstract][Full Text] [Related]
11. A theoretical approach to the problem of dose-volume constraint estimation and their impact on the dose-volume histogram selection.
Schinkel C; Stavrev P; Stavreva N; Fallone BG
Med Phys; 2006 Sep; 33(9):3444-59. PubMed ID: 17022241
[TBL] [Abstract][Full Text] [Related]
12. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
[TBL] [Abstract][Full Text] [Related]
14. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model.
Koelbl O; Richter S; Flentje M
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1193-8. PubMed ID: 10613312
[TBL] [Abstract][Full Text] [Related]
15. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
16. Dose-volume and radiobiological dependence on the calculation grid size in prostate VMAT planning.
Chow JCL; Jiang R
Med Dosim; 2018 Winter; 43(4):383-389. PubMed ID: 29373184
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.
Metwaly M; Awaad AM; El-Sayed EM; Sallam ASM
J Appl Clin Med Phys; 2008 Oct; 9(4):37-56. PubMed ID: 19020481
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
[TBL] [Abstract][Full Text] [Related]
19. Novel lung IMRT planning algorithms with nonuniform dose delivery strategy to account for respiratory motion.
Li X; Zhang P; Mah D; Gewanter R; Kutcher G
Med Phys; 2006 Sep; 33(9):3390-8. PubMed ID: 17022235
[TBL] [Abstract][Full Text] [Related]
20. Predicting dose-volume histograms for organs-at-risk in IMRT planning.
Appenzoller LM; Michalski JM; Thorstad WL; Mutic S; Moore KL
Med Phys; 2012 Dec; 39(12):7446-61. PubMed ID: 23231294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
